MATTAREI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 6.126
AS - Asia 3.279
EU - Europa 2.236
SA - Sud America 833
AF - Africa 832
OC - Oceania 97
Continente sconosciuto - Info sul continente non disponibili 32
Totale 13.435
Nazione #
US - Stati Uniti d'America 5.710
SG - Singapore 1.130
CN - Cina 648
IT - Italia 571
BR - Brasile 548
VN - Vietnam 348
HK - Hong Kong 318
DE - Germania 186
FI - Finlandia 147
GB - Regno Unito 134
PL - Polonia 120
NL - Olanda 98
SE - Svezia 95
FR - Francia 92
RU - Federazione Russa 86
BJ - Benin 77
IN - India 72
CI - Costa d'Avorio 70
AR - Argentina 54
CA - Canada 53
MX - Messico 51
JP - Giappone 50
UA - Ucraina 49
AT - Austria 45
ID - Indonesia 43
ES - Italia 41
KR - Corea 41
TR - Turchia 39
IE - Irlanda 38
CO - Colombia 37
EC - Ecuador 34
CL - Cile 32
UZ - Uzbekistan 32
SA - Arabia Saudita 31
ZA - Sudafrica 31
AO - Angola 29
AU - Australia 29
PY - Paraguay 29
SK - Slovacchia (Repubblica Slovacca) 29
SI - Slovenia 28
AL - Albania 27
RO - Romania 27
CH - Svizzera 26
DK - Danimarca 26
IQ - Iraq 26
IR - Iran 26
PH - Filippine 26
CY - Cipro 25
LB - Libano 25
LU - Lussemburgo 25
MA - Marocco 25
PK - Pakistan 25
YE - Yemen 25
BY - Bielorussia 24
DO - Repubblica Dominicana 24
KH - Cambogia 24
RS - Serbia 24
HN - Honduras 23
PE - Perù 23
AE - Emirati Arabi Uniti 22
BF - Burkina Faso 22
BZ - Belize 22
KE - Kenya 22
KG - Kirghizistan 22
MK - Macedonia 22
NG - Nigeria 22
NO - Norvegia 22
TT - Trinidad e Tobago 22
BA - Bosnia-Erzegovina 21
BG - Bulgaria 21
GR - Grecia 21
LY - Libia 21
MD - Moldavia 21
MG - Madagascar 21
NP - Nepal 21
UY - Uruguay 21
VE - Venezuela 21
CU - Cuba 20
CZ - Repubblica Ceca 20
ML - Mali 20
TN - Tunisia 20
AD - Andorra 19
BO - Bolivia 19
CV - Capo Verde 19
EG - Egitto 19
ET - Etiopia 19
GT - Guatemala 19
JM - Giamaica 19
ME - Montenegro 19
PT - Portogallo 19
TW - Taiwan 19
TZ - Tanzania 19
AZ - Azerbaigian 18
CW - ???statistics.table.value.countryCode.CW??? 18
EE - Estonia 18
JO - Giordania 18
MR - Mauritania 18
MZ - Mozambico 18
NI - Nicaragua 18
NZ - Nuova Zelanda 18
Totale 12.591
Città #
Ashburn 795
Fairfield 677
Singapore 585
Chandler 429
Woodbridge 413
Houston 329
Hong Kong 296
Ann Arbor 285
Seattle 275
Cambridge 262
Beijing 243
Wilmington 209
Boardman 158
Padova 145
Santa Clara 119
Dong Ket 106
Los Angeles 102
New York 95
Munich 84
Ho Chi Minh City 80
San Diego 80
Cotonou 76
Abidjan 69
Princeton 66
Helsinki 59
Bytom 58
Medford 54
Hanoi 46
São Paulo 46
Hefei 41
Buffalo 40
Chicago 40
Des Moines 37
Turku 37
Roxbury 36
Warsaw 36
Milan 35
Dublin 30
Rome 30
Brooklyn 28
Jacksonville 28
Nanjing 28
Padua 28
Tokyo 28
Vienna 28
Tashkent 27
Montreal 25
Verona 25
Luanda 24
London 23
Phnom Penh 23
Rio de Janeiro 23
Bishkek 22
Denver 21
Tirana 20
Andorra la Vella 19
Antananarivo 19
Bamako 19
Dallas 19
Ljubljana 19
Salt Lake City 19
Seoul 19
Dakar 18
Lusaka 18
Managua 18
Montevideo 18
Nairobi 18
Addis Ababa 17
Amman 17
Baku 17
Havana 17
Lappeenranta 17
Luxembourg 17
Orem 17
Redondo Beach 17
Sanaa 17
Stockholm 17
Ulan Bator 17
Belo Horizonte 16
Boston 16
Dushanbe 16
Phoenix 16
Willemstad 16
Belgrade 15
Belize City 15
Bridgetown 15
Castries 15
Conakry 15
Dili 15
Frankfurt am Main 15
Guangzhou 15
Kigali 15
Lima 15
Noumea 15
Ouagadougou 15
Podgorica 15
Tallinn 15
Asunción 14
Atlanta 14
Auckland 14
Totale 7.746
Nome #
Impaired Mitochondrial ATP Production Downregulates Wnt Signaling via ER Stress Induction 302
A Synthetic Fluorescent Mitochondria-Targeted Sensor for Ratiometric Imaging of Calcium in Live Cells 301
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo 281
Small-molecule modulators of mitochondrial channels as chemotherapeutic agents 252
A novel inhibitor prevents the peripheral neuroparalysis of Botulinum neurotoxins 242
Hsp90 is involved in the entry of clostridial neurotoxins into the cytosol of nerve terminals 235
Development of mitochondria-targeted derivatives of resveratrol 234
A mitochondriotropic derivative of quercetin: a strategy to increase the effectiveness of polyphenols 232
An Agonist of the CXCR4 Receptor Strongly Promotes Regeneration of Degenerated Motor Axon Terminals 216
New natural amino acid-bearing prodrugs boost pterostilbene's oral pharmacokinetic and distribution profile 205
Amino acid carbamates as prodrugs of resveratrol 203
Cytotoxicity of a mitochondriotropic quercetin derivative: Mechanisms 200
Regulation of Proliferation by a Mitochondrial Potassium Channel in Pancreatic Ductal Adenocarcinoma Cells 196
A CXCR4 receptor agonist strongly stimulates axonal regeneration after damage 195
Synthesis of resveratrol sulfates: turning a nightmare into a dream 192
Derivati dello psoralene come agenti anti-tumorali selettivi 190
Acetal Derivatives as Prodrugs of Resveratrol. 189
Impact of mitochondriotropic quercetin derivatives on mitochondria 187
PH-Controlled Liposomes for Enhanced Cell Penetration in Tumor Environment 186
Cytotoxicity of mitochondria-targeted resveratrol derivatives: interactions with respiratory chain complexes and ATP synthase. 186
Novel lipid-mimetic prodrugs delivering active compounds to adipose tissue 185
Resveratrol derivatives as a pharmacological tool 184
Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family 179
Redox Properties and Cytotoxicity of Synthetic Isomeric Mitochondriotropic Derivatives of the Natural Polyphenol Quercetin 178
Pharmacokinetics and tissue distribution of pterostilbene in the rat 172
Improving the efficacy of plant polyphenols. 169
Multiple Mechanisms Converging on Transcription Factor EB Activation by the Natural Phenol Pterostilbene 169
Regioselective O-Derivatization of Quercetin via Ester Intermediates. An Improved Synthesis of Rhamnetin and Development of a New Mitochondriotropic Derivative 166
Synthesis and Evaluation as Prodrugs of Hydrophilic Carbamate Ester Analogues of Resveratrol 164
Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds 163
New Water-Soluble Carbamate Ester Derivatives of Resveratrol 162
An agonist of the CXCR4 receptor accelerates the recovery from the peripheral neuroparalysis induced by Taipan snake envenomation 161
Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model 160
Absorption and metabolism of resveratrol carboxyesters and methanesulfonate by explanted reat intestinal segments 159
Mitochondria-targeted resveratrol derivatives act as cytotoxic pro-oxidants. 158
Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca2+ accumulation in spinobulbar muscular atrophy skeletal muscle 157
Synthesis and cellular effects of a mitochondria-targeted inhibitor of the two-pore potassium channel TASK-3 157
An angiopep2-paptp construct overcomes the blood-brain barrier. New perspectives against brain tumors 153
Novel mitochondria-targeted furocoumarin derivatives as possible anti-cancer agents 152
EGA protects mammalian cells from clostridiumdifficile CDT, clostridium perfringens iota toxin clostridium botulinum C2 toxin 151
Potential anti-cancer activity of 7-O-pentyl quercetin: Efficient, membrane-targeted kinase inhibition and pro-oxidant effect 150
Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells 150
Water and Electrolyte Content in Hypertension in the Skin (WHYSKI) in Primary Aldosteronism 149
The mode of dexamethasone decoration influences avidin-nucleic-acid-nano-assembly organ biodistribution and in vivo drug persistence 149
Corrigendum to “Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family” [Redox Biol. 37 (2020 Sep 6) 101705–101721](S2213231720309101)(10.1016/j.redox.2020.101705) 148
Soluble polyphenols: synthesis and bioavailability of 3,4',5-tri(alpha-D-glucose-3-O-succinyl)resveratrol 144
Synthesis and Testing of Novel Isomeric Mitochondriotropic Derivatives of Resveratrol and Quercetin 143
N-monosubstituted methoxy-oligo(ethylene glycol) carbamate ester prodrugs of resveratrol 143
Nuovi derivati del resveratrolo 139
An Agonist of the CXCR4 Receptor is therapeutic for the neuroparalysis induced by Bungarus snakes envenoming 139
Resveratrol and health: the starting point. 138
The mitochondrial ATP-dependent potassium channel (mitoKATP) controls skeletal muscle structure and function 138
Mt-fura-2, a Ratiometric Mitochondria-Targeted Ca2+ Sensor. Determination of Spectroscopic Properties and Ca2+ Imaging Assays 137
Mitochondrial calcium uptake declines during aging and is directly activated by oleuropein to boost energy metabolism and skeletal muscle performance 135
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial 133
Novel small molecule inhibitors that prevent the neuroparalysis of tetanus neurotoxin 132
Quercetin Mitochondriotropic Derivatives Antagonize Nitrate Tolerance and Endothelial Dysfunction of Isolated Rat Aorta Rings 131
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial 131
N-methyl-D-aspartate Receptors and Depression: Linking Psychopharmacology, Pathology and Physiology in a Unifying Hypothesis for the Epigenetic Code of Neural Plasticity 128
New Synthesis and Pharmacological Evaluation of Enantiomerically Pure (R)- and (S)-Methadone Metabolites as N-Methyl-d-aspartate Receptor Antagonists 127
Altered MICOS Morphology and Mitochondrial Ion Homeostasis Contribute to Poly(GR) Toxicity Associated with C9-ALS/FTD 127
Efficient SARS-CoV-2 infection antagonization by rhACE2 ectodomain multimerized onto the Avidin-Nucleic-Acid-NanoASsembly 126
LETM1-Mediated K+ and Na+ Homeostasis Regulates Mitochondrial Ca2+ Efflux 124
Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo 122
Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model 120
Development of derivatives of natural polyphenols for pharmacological applications 119
Esmethadone-HCl (REL-1017): a promising rapid antidepressant 114
Dispersity within brushes plays a major role in determining their interfacial properties: The case of oligoxazoline-based graft polymers 112
A novel mertansine conjugate for acid-reversible targeted drug delivery validated through the Avidin-Nucleic-Acid-NanoASsembly platform 111
A Photo-Crosslinkable Biotin Derivative of the Phosphoantigen (E)-4-Hydroxy-3-Methylbut-2-Enyl Diphosphate (HMBPP) Activates Vγ9Vδ2 T Cells and Binds to the HMBPP Site of BTN3A1 107
Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder 106
Drug–Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism 105
DA7R: A 7-Letter Zip Code to Target PDAC 104
Semicarbazone EGA inhibits uptake of diphtheria toxin into human cells and protects cells article from intoxication 100
Pharmacokinetics, Tolerability, and Safety of Esmethadone in Subjects with Chronic Kidney Disease or Hepatic Impairment 99
The Structural Dispersity of Oligoethylene Glycol-Containing Polymer Brushes Determines Their Interfacial Properties 97
Nanocostrutti comprendenti nanoparticelle lipidiche solide rivestite da un guscio idrofilo 96
Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling 91
ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A 30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE 87
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users 83
Sphingosine is involved in PAPTP-induced death of pancreas cancer cells by interfering with mitochondrial functions 81
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma 80
Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone’ 77
The Role of Structural Dispersity of Polymer Brushes in Determining the Colloidal Stability of Core–Shell Nanoparticles and Their Interaction with Anti-PEG Antibodies 77
Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors 74
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017) 70
null 66
The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin 65
Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder 60
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases 46
Mitapivat metabolically reprograms human β-thalassemic erythroblasts, increasing their responsiveness to oxidation 43
Small molecule OPA1 inhibitors amplify cytochrome c release and reverse cancer cells resistance to Bcl-2 inhibitors 41
Emerging mechanisms of psilocybin-induced neuroplasticity 38
Dexamethasone conjugation to an Avidin-Nucleic-Acid-NanoASsembly eliminates the steroid plasma absorption, enhancing selective lung tropism in a murine model of pulmonary fibrosis 36
Doxorubicin liposomes cell penetration enhancement and its potential drawbacks for the tumor targeting efficiency 33
Mito-Genipin, a Novel Mitochondria-Targeted Genipin Derivative Modulates Oxidative Stress and Inflammation in Macrophages 22
Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivo 19
Totale 13.585
Categoria #
all - tutte 42.329
article - articoli 39.885
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.139
selected - selezionate 0
volume - volumi 887
Totale 84.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021748 0 0 0 0 95 35 17 63 102 181 110 145
2021/20221.006 27 116 104 46 81 72 59 107 82 33 74 205
2022/2023848 134 88 12 125 106 120 3 77 80 19 67 17
2023/2024684 42 81 76 49 64 94 48 47 17 23 60 83
2024/20252.465 25 152 111 114 229 92 162 213 201 114 426 626
2025/20265.757 674 845 1.476 1.722 1.040 0 0 0 0 0 0 0
Totale 13.585